"anti inflammatory protein" trang 12 - tải miễn phí từ tailieunhanh
Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study

Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study
11    51    1
Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model

Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model
13    50    1
Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513

Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513
10    47    1
Molecular chess? Hallmarks of anti-cancer drug resistance

Molecular chess? Hallmarks of anti-cancer drug resistance
8    52    1
Plant based anti-cancerous superfoods, boosting immunity: A coherent critique

Plant based anti-cancerous superfoods, boosting immunity: A coherent critique
9    33    1
Profound reduction in tamoxifen active metabolite endoxifen in a breast cancer patient treated with rifampin prior to initiation of an anti-TNFα biologic for ulcerative colitis: A case report

Profound reduction in tamoxifen active metabolite endoxifen in a breast cancer patient treated with rifampin prior to initiation of an anti-TNFα biologic for ulcerative colitis: A case report
6    46    1
CPA-7 influences immune profile and elicits anti-prostate cancer effects by inhibiting activated STAT3

CPA-7 influences immune profile and elicits anti-prostate cancer effects by inhibiting activated STAT3
10    49    1
The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts

The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts
9    42    1
A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors

A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors
10    54    1
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients

Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients
11    32    1
Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells

Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells
13    54    1
Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol

Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol
11    62    1
Age-dependent changes in anti-Müllerian hormone levels in Lebanese females: Correlation with basal FSH and LH levels and LH/FSH ratio: A cross-sectional study

Age-dependent changes in anti-Müllerian hormone levels in Lebanese females: Correlation with basal FSH and LH levels and LH/FSH ratio: A cross-sectional study
6    49    2
Clinical efficacy of various anti-hypertensive regimens in hypertensive women of Punjab; a longitudinal cohort study

Clinical efficacy of various anti-hypertensive regimens in hypertensive women of Punjab; a longitudinal cohort study
12    73    2
Study on skin sensitization potential of an anti - tumor necrosis factor - alpha receptor fusion protein in guinea pigs

Study on skin sensitization potential of an anti - tumor necrosis factor - alpha receptor fusion protein in guinea pigs
10    46    1
Pharmacological evaluation of Xanthoxylum oxyphyllum edgew extract with special reference to anti-inflammatory activity

Pharmacological evaluation of Xanthoxylum oxyphyllum edgew extract with special reference to anti-inflammatory activity
7    26    1
Pathological evaluation of anti-tumour effects of withaferin a against experimentally induced mammary tumour in rats

Pathological evaluation of anti-tumour effects of withaferin a against experimentally induced mammary tumour in rats
10    20    1
Evaluation of anti-tumour effects of withaferin a using molecular markers in a rat model of mammary carcinogenesis

Evaluation of anti-tumour effects of withaferin a using molecular markers in a rat model of mammary carcinogenesis
10    32    1
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis

A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
7    29    1
Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer

Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer
9    36    1
crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.